WHO DIAMOND PROJECT
Insulin-dependent diabetes mellitus (IDDM) is one of the most important
chronic diseases of children worldwide. A 60-fold international gradient
in IDDM incidence has been reported and epidemic periods have been
identified. The World Health Organization (WHO) Multinational Project for
Childhood Diabetes (WHO DIAMOND Project) has been developed to investigate
and characterize global incidence, mortality and health care. Over 10
years (1990-1999), this study will collect population-based data
IDDM in more than 100 centers in 60 countries worldwide.
The goals of the DIAMOND Project are to:
collect standard information on incidence, risk
factors, complications and mortality associated with IDDM;
evaluate the efficiency and effectiveness of health
care and the economics of diabetes;
establish national and international training
programs in diabetes epidemiology.
It is hoped that the DIAMOND Project will be instrumental for the
prevention of this serious disease and its sequelae.
Helsinki Coordinating Center
Dr. Jaakko Tuomilehto, Dr. Marjatta Karvonen
National Public Health Institute
Department of Epidemiology and Health Promotion
FIN 00300 Helsinki, Finland
Pittsburgh Coordinating Center
Dr. Ronald LaPorte, Dr. Ingrid Libman
Rangos Research Center
Children's Hospital of Pittsburgh
3460 Fifth Avenue - 5th floor
Pittsburgh, PA 15213, USA
Tel.: (412) 692-5200 or (412) 692-5822
Fax: (412) 692-8329
Internet: firstname.lastname@example.org or email@example.com
Dr. Hilary King
Diabetes and Other Noncommunicable Diseases Unit
Division of Noncommunicable Diseases and Health Technology
World Health Organization
1211 Geneva 27
At present 167 centers from 69 countries are participating in the
DIAMOND Incidence component. Data is now available from more than
half of the centers. The highest incidence in the world is in Northern
Euroe, but within the continent there are striking exceptions as in
Iceland the incidence is only half of that in Norway and Sweden and
one-third of that in Finland. By contrast, in Sardinia, in Southern
Europe, the incidence is almost as high as in Finland, three times
higher than the overall incidence in Europe. The lowest incidence is
seen in Japan, Korea and Mexico.
Case-Control Molecular epidemiology studies are being
carried out to assess the contribution of HLA alleles to the incidence
of IDDM within and between populations. Data from case-control studies are
available from 18 populations, including high, medium and low risk areas
and various racial groups.
Complications Substudy (DIACOMP)
14 - July 1996
13 - February 1995
12 - August 1994
11 - July 1993
This homepage was created by Dr. Ingrid M. Libman. Special thanks to Dr.
Deborah Aaron for her help with the graphics.